Stem cell growth factor shows promise as Alzheimer's treatment

07/2/2009 | New Kerala (India)

A U.S. study on Alzheimer's disease mice models found that injections of the granulocyte-colony stimulating factor -- a human growth factor used to trigger blood stem cell production in the bone marrow -- reduced the levels of beta amyloid protein that is considered a hallmark of the disease, as well as increased neuron production and promoted nerve-cell connections. The results indicate that the growth factor shows promise as a treatment "that may actually reverse disease, not just alleviate symptoms like currently available drugs," the lead author said.

View Full Article in:

New Kerala (India)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Confidential
Pompano Beach, FL